missing translation for 'onlineSavingsMsg'
Learn More

Coagulation Factor XIV/Protein C Antibody (PC 7), HRP, Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals NBP1-05113H

Product Code. 18226142

  • £499.00 / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

Coagulation Factor XIV/Protein C Monoclonal specifically detects Coagulation Factor XIV/Protein C in Human samples. It is validated for ELISA.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

Coagulation Factor XIV/Protein C
Monoclonal
HRP
PBS with No Preservative
PROC
Recombinant form of human activated protein C (Drotrecogin alfa, Xigris)
0.1 mL
Apoptosis, Cancer
5624
Human, Non-species specific
Purified
ELISA
PC 7
ELISA
Anticoagulant protein C, APC, Autoprothrombin IIA, Blood coagulation factor XIV, EC 3.4.21, EC 3.4.21.69, PC, PROC1, protein C (inactivator of coagulation factors Va and VIIIa), vitamin K-dependent protein C
Mouse
Protein A purified
RUO
Primary
Has specificity for a conformation dependent neoepitope that is expressed in activated protein C upon complex-formation with alpha1-antitrypsin. No reaction is seen to non-complexed alpha1-antitrypsin and only very little cross reaction to protein C zymogen. Note that specificity is calcium dependent.
Store at 4C in the dark.
IgG1 κ
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.